{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:52:56Z","timestamp":1790362376230,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ygyno.2017.12.026","type":"journal-article","created":{"date-parts":[[2017,12,28]],"date-time":"2017-12-28T08:59:44Z","timestamp":1514451584000},"page":"485-490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["The utility of sentinel lymph node mapping in the management of endometrial atypical hyperplasia"],"prefix":"10.1016","volume":"148","author":[{"given":"Omar","family":"Touhami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Gr\u00e9goire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Renaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Sebastianelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Grondin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2298-7913","authenticated-orcid":false,"given":"Marie","family":"Plante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2017.12.026_bb0005","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S0002-9378(96)70599-9","article-title":"Use of computerized morphometric analyses of endometrial hyperplasias in the prediction of coexistent cancer","volume":"174","author":"Dunton","year":"1996","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2017.12.026_bb0010","first-page":"413","article-title":"Practice bulletin, clinical management guidelines for obstetrician gynecologists, number 65, August 2005: management of endometrial cancer","volume":"106","author":"ACOG","year":"2005","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2017.12.026_bb0015","doi-asserted-by":"crossref","unstructured":"Whyte JS, Gurney EP, Curtin JP, Blank SV. Lymph node dissection in the surgical management of atypical endometrial hyperplasia. Am. J. Obstet. Gynecol. 2010 Feb;202(2):176.e1\u20134.","DOI":"10.1016\/j.ajog.2009.10.855"},{"issue":"3","key":"10.1016\/j.ygyno.2017.12.026_bb0020","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ygyno.2014.10.008","article-title":"Clinically significant endometrial cancer risk following a diagnosis of complex atypical hyperplasia","volume":"135","author":"Costales","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.12.026_bb0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(08)61766-3","article-title":"Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomized study","volume":"373","author":"Kitchener","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2017.12.026_bb0030","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/djn397","article-title":"Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial","volume":"100","author":"Benedetti Panici","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.ygyno.2017.12.026_bb0035","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/cncr.21663","article-title":"Problems with the current diagnostic approach to complex atypical endometrial hyperplasia","volume":"106","author":"Soslow","year":"2006","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2017.12.026_bb0040","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/cncr.21649","article-title":"Reproducibility of the diagnosis of atypical endometrial hyperplasia: a gynecologic oncology group study","volume":"106","author":"Zaino","year":"2006","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2017.12.026_bb0045","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00000478-199504000-00001","article-title":"Proposed criteria for the diagnosis of well differentiated endometrial carcinoma. A diagnostic test for myoinvasion","volume":"19","author":"Longacre","year":"1995","journal-title":"Am. J. Surg. Pathol."},{"issue":"1","key":"10.1016\/j.ygyno.2017.12.026_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAP.0b013e3181919e15","article-title":"Low-grade endometrial adenocarcinoma: a diagnostic algorithm for distinguishing atypicalendometrial hyperplasia and other benign (and malignant) mimics","volume":"16","author":"McKenney","year":"2009","journal-title":"Adv. Anat. Pathol."},{"issue":"12","key":"10.1016\/j.ygyno.2017.12.026_bb0055","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1002\/ijc.30707","article-title":"Risk factors for lymph node metastases in women with endometrial cancer: a population-based, nation-wide register study-on behalf of the Swedish gynecological cancer group","volume":"140","author":"St\u00e5lberg","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2017.12.026_bb0060","series-title":"WHO Classification of Tumours of Female Reproductive Organs","first-page":"121","article-title":"Tumours of the uterine corpus","author":"Zaino","year":"2014"},{"key":"10.1016\/j.ygyno.2017.12.026_bb0065","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ygyno.2015.03.004","article-title":"Sentinel node mapping with indocyanine green and endoscopic near-infrared fluorescence imaging in endometrial cancer. A pilot study and review of the literature","volume":"137","author":"Plante","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.12.026_bb0070","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/cncr.21650","article-title":"Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia","volume":"106","author":"Trimble","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2017.12.026_bb0075","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00003081-198203000-00006","article-title":"Definitions of endometrial carcinoma precursors","volume":"25","author":"Scully","year":"1982","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2017.12.026_bb0080","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2559.1982.tb02747.x","article-title":"The endometrial hyperplasias and their relationship to endometrial neoplasia","volume":"6","author":"Fox","year":"1982","journal-title":"Histopathology"},{"key":"10.1016\/j.ygyno.2017.12.026_bb0085","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The behavior of endometrial hyperplasia. A long-term study of \u201cuntreated\u201d hyperplasia in 170 patients","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2017.12.026_bb0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ygyno.2013.06.037","article-title":"Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer","volume":"131","author":"AlHilliMM","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.12.026_bb0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ygyno.2008.01.023","article-title":"Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging","volume":"109","author":"Mariani","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.12.026_bb0100","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1447-0756.2004.00178.x","article-title":"Coexisting endometrial cancer in patients with preoperative diagnosis of atypical endometrial hyperplasia","volume":"30","author":"Bilgin","year":"2004","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"5","key":"10.1016\/j.ygyno.2017.12.026_bb0105","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1016\/j.ajog.2006.10.886","article-title":"The accuracy of frozen pathology at time of hysterectomy in patients with complex atypically hyperplasia on preoperative biopsy","volume":"196","author":"Indermaur","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.ygyno.2017.12.026_bb0110","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ygyno.2017.10.020","article-title":"Use of a novel sentinel lymph node mapping algorithm reduces the need for pelvic lymphadenectomy in low-grade endometrial cancer","volume":"147","author":"Tanner","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2017.12.026_bb0115","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ygyno.2017.05.024","article-title":"Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: does adjuvant treatment matter?","volume":"146","author":"Plante","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2017.12.026_bb0120","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00432-016-2303-4","volume":"143","author":"Papadia","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2017.12.026_bb0125","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/01.AOG.0000149151.74863.c4","article-title":"Surgical staging for patients presenting with grade 1 endometrial carcinoma","volume":"105","author":"Ben-Shachar","year":"2005","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2017.12.026_bb0130","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ygyno.2008.07.033","article-title":"Accuracy of preoperative endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma","volume":"111","author":"Leitao","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"2 Pt 1","key":"10.1016\/j.ygyno.2017.12.026_bb0135","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/AOG.0b013e318240de51","article-title":"Nodal metastasis risk in endometrioid endometrial cancer","volume":"119","author":"Milam","year":"2012","journal-title":"Obstet. Gynecol."},{"issue":"9","key":"10.1016\/j.ygyno.2017.12.026_bb0140","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S1701-2163(16)34657-6","article-title":"Preoperative CA 125 tumour marker in endometrial cancer: correlation with advanced stage disease","volume":"32","author":"Sebastianelli","year":"2010","journal-title":"J. Obstet. Gynaecol. Can."},{"issue":"2","key":"10.1016\/j.ygyno.2017.12.026_bb0145","doi-asserted-by":"crossref","first-page":"497","DOI":"10.7314\/APJCP.2016.17.2.497","article-title":"The value of preoperative CA 125 levels in prediction of myometrial invasion in patients with early-stage endometrioid-type endometrial cancer","volume":"17","author":"Atguden","year":"2016","journal-title":"Asian Pac. J. Cancer Prev."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817316177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817316177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T16:11:44Z","timestamp":1570551104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825817316177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0090825817316177"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.12.026","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The utility of sentinel lymph node mapping in the management of endometrial atypical hyperplasia","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.12.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}